Realistically speaking the reason I and I'm sure everyone else is holding or buying shares in CBBT is because of the pending acquisition.
Logically speaking, I could see why Cerebain Biotech would want to purchase PKG,for their well established operation and their revenue stream. But, why would a company like PKG, be willing to be purchased by a company like Cerebain Biotech. The only thing that makes sense is that, besides being a public company, Cerebain Biotech has in some form or another a means to treat or cure dementia and or alzheimer, which would be worth billions.
I believe the delay in finalizing the acquisition is in the terms that will govern it, as PKG wants to keep their independence.
I believe the acquisition will be finalized in a few more weeks or sooner as it would be a win win situation for all.
AIMO
